Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million February 20, 2017 Arrowhead Pharma Adopts Stockholder Rights Agreement March 22, 2017 Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program February 26, 2018
Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million February 20, 2017
Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program February 26, 2018
